Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/21/2005EP1155123A4 Novel adc polynucleotides and polypeptides, uses thereof including methods for improving seeds
12/21/2005EP1119581B1 USE OF A VECTOR EXPRESSING RB2/p130 FOR PREVENTION OR TREATMENT OF RESTENOSIS OR ATHEROSCLEROTIC PLAQUES
12/21/2005EP1117816B1 Method of plant transformation
12/21/2005EP1112375B1 Biosensor
12/21/2005EP1080182B1 Method of incorporating amino acid analogs using a hypertonic growth medium
12/21/2005EP1004238B1 Transgenic pigs
12/21/2005EP1000167B1 Production of human mutant proteins in human cells by homologous recombination
12/21/2005EP1000143B1 Frazzled nucleotide sequences, expression products, compositions and uses
12/21/2005EP0994947B1 Mu-1, member of the cytokine receptor family
12/21/2005EP0979235B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof
12/21/2005EP0975766B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
12/21/2005EP0956338B1 Host cells and methods of producing proteins
12/21/2005EP0920524B1 A short-shafted adenoviral fiber and its use
12/21/2005EP0822988B1 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
12/21/2005EP0809705B1 Nucleic acid-containing composition, preparation and use thereof
12/21/2005EP0783573B1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides
12/21/2005EP0702692B1 Regulation of antigen presentation
12/21/2005EP0698108B2 Adenoviral vectors of animal origin and use thereof in gene therapy
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1711355A Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof
12/21/2005CN1711283A Kit for assaying human low-molecular weight CD14 and antibody
12/21/2005CN1711281A Use of EDG2 receptor in an animal model of heart failure
12/21/2005CN1711105A Compositions and methods for treating or preventing pneumococcal infection
12/21/2005CN1711018A Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof
12/21/2005CN1710107A Method and reagent for predicting tetanic rachitis susceptibility
12/21/2005CN1710106A Method and reagent for predicting diabetes II susceptibility
12/21/2005CN1710081A Method for promoting ultrosonic mediated gene transfection by copolymer
12/21/2005CN1710080A Survivin mutant recombinant adenovirus with tumour cell death-promoting function and method for obtaining same
12/21/2005CN1710079A Carrier pcSH1-n capable of concurrently expressing multiple shRNA and its constructing method
12/21/2005CN1710078A Method for preparing and identifying domain protein monoclonal antibody with leucine zipper structure
12/21/2005CN1710077A Method for rapid amplifying nemato phagous fungi extracellular serine proteinase gene and its use
12/21/2005CN1710076A Use of boea crassifolia BcBCP1 gene for breeding drought-salt-tolerant plants
12/21/2005CN1710075A Wheat somatic cell hybrid analogous 13 glutelin sub-gene nucleic acid sequence and use
12/21/2005CN1710074A Tumour drug-resistant marker gene and its pharmaceutical use
12/21/2005CN1710073A Recombinant calmette-Guerin bacillus vaccine for secretion of tumour necrosis factor-alpha and its constructing method
12/21/2005CN1710072A Recombinant calmette-Guerin bacillus vaccine for secretion of human interferon-2 and its constructing method
12/21/2005CN1710071A Recombinant calmette-Guerin bacillus vaccine for secretion of human interferon-alphaza and its constructing method
12/21/2005CN1232823C Skin absorbing detecting method for article to be detected
12/21/2005CN1232816C Alkali sequence inspecting electrode and device and its inspecting method
12/21/2005CN1232648C Method for producing antigen protein in use for hog cholera vaccine
12/21/2005CN1232646C Plants having altered amino acid contents and method for production thereof
12/21/2005CN1232645C Method for protecting plants
12/21/2005CN1232644C Optimization method for activation of endogenetic gene of cell
12/21/2005CN1232643C Nucleic acid vaccine
12/21/2005CN1232642C Inflammatory inhibiting factor Fwa116
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232639C Gamma-tocopherol methyltransferase, gene and use thereof
12/21/2005CN1232638C Transgenic plant resistant to mycotoxins and methods
12/21/2005CN1232537C Heavy chain variable region single domain antibody reinforced fusion protein VH-LDP-AE
12/21/2005CN1232536C Human stem cell factor macrophage colony stimulating factor bifunction protein and its preparation
12/21/2005CN1232535C GST fusion expression of conotoxin MVII A gene and its use
12/21/2005CN1232534C Heteroprotein of melanoma EPI (Mage-1, HLA-Al) and bacteriophage coat protein and its application
12/21/2005CN1232532C Fibroblast growth factor-2 analogue, producing process and application thereof
12/21/2005CN1232530C Ethene receptor protein of wheat and its coding sequence
12/21/2005CN1232343C Devices and methods for carrying out chemical reactions using photobiological reagents
12/21/2005CN1232304C Functional fragment antigen of tetanus toxin and tetanus vaccine
12/21/2005CN1232303C Use of gene NMESI related to esophageal carcinoma and encoded polypeptide
12/20/2005US6977325 Genetic engineering of maize ubiquitin promoter to increase expression levels beyond those observed with the native type and alter tissue preference; sequence includes modification so that it does not include two overlapping heat shock elements
12/20/2005US6977297 Methods and means for modification of glucosinolates in plants
12/20/2005US6977296 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
12/20/2005US6977295 Locked nucleic acid hybrids and methods of use
12/20/2005US6977293 Chimeric polypeptides
12/20/2005US6977244 Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/20/2005US6977178 System and method for transgenic and targeted mutagenesis screening
12/20/2005US6977176 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance
12/20/2005US6977174 Circular DNA molecule with conditional origin of replication, method for preparing the same and use thereof in gene therapy
12/20/2005US6977172 Electroporation apparatus for use in the transfer of nucleotide sequences into cells
12/20/2005US6977165 Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same
12/20/2005US6977161 Solid support assay systems and methods utilizing non-standard bases
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977157 Clock gene promoter
12/20/2005US6977154 Nucleic acid binding proteins
12/20/2005US6977153 Rolling circle amplification of RNA
12/20/2005US6977150 Process and compositions for peptide, protein and peptidomimetic synthesis
12/20/2005US6977147 Method of screening therapeutic or preventative agents for squamous epithelial cell carcinoma
12/20/2005US6977146 treated with bisulfite; enzymatic amplification; amplified portions are immobilized and hybridized with mass- and/or charge-tagged nucleic acid probes; analysis and classification using matrix-assisted laser desorption/ionization mass spectrometry
12/20/2005US6977145 Method for carrying out a biochemical protocol in continuous flow in a microreactor
12/20/2005US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides;
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/20/2005US6977072 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005CA2343318C Methods of identifying and characterizing mutations within bacterial dna gyrase and fabi
12/20/2005CA2343000C Method for making insertional mutations
12/20/2005CA2328903C Compounds capable of cleaving double-stranded dna and method of utilization of the same
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
12/20/2005CA1341491C Preparation of human igf and egf via recombinant dna technology
12/18/2005CA2509049A1 Production of mutant strain of aspergillus fumigatus, method and assay for inhibiting siderophore biosynthesis and diagnostic method for detecting likely aspergillus fumigatus infection
12/18/2005CA2472695A1 Production of mutant strain of aspergillus fumigatus and method and assay for inhibiting siderophore biosynthesis
12/15/2005WO2005119244A1 Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
12/15/2005WO2005118874A1 Enhancing protein expression
12/15/2005WO2005118866A2 COMPOSITIONS AND METHODS FOR SYNTHESIZING cDNA
12/15/2005WO2005118864A2 Antibodies and related molecules that bind to psca proteins
12/15/2005WO2005118861A2 Compositions and methods for producing libraries with controlled compositions and screening probabilites
12/15/2005WO2005118843A1 Compositions and methods
12/15/2005WO2005118841A1 Assay of ubiquitinization of synoviolin and use thereof in screening
12/15/2005WO2005118835A2 Cell lines and methods for evaluating integrating polynucleotides
12/15/2005WO2005118825A2 Chimeric adenoviruses for use in cancer treatment
12/15/2005WO2005118823A2 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005WO2005118822A2 Generation of plants with altered oil content
12/15/2005WO2005118821A2 Generation of plants with altered oil content